Development · 17 Aug 2026
1 publisher has reported this development. Each act of reporting is below, cited.
Molbio Diagnostics IPO is set to list on NSE and BSE on August 17, 2026, after receiving 70.26 times subscription during its three-day bidding period from August 10-12, 2026.
Molbio Diagnostics IPO will be listed on NSE and BSE on Monday, 17 August 2026, after receiving 70.26 times overall subscription.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.